Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison Between Moderate-high Interval Exercise and Moderate Continuous Exercise in an Advanced Cardiac Rehabilitation Program

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02162290
Recruitment Status : Completed
First Posted : June 12, 2014
Last Update Posted : May 17, 2016
Sponsor:
Information provided by (Responsible Party):
Assaf-Harofeh Medical Center

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

The research will study the differences between interval training and continuous training among cardiac patients in a cardiac rehabilitation facility.

The main objectives are:

  1. Functional capacity measures (VO2 max).
  2. Cardiac risk factors
  3. Quality of life assessments.

Study hypothesis:

Interval training will be more effective in improving functional capacity, cardiac risk factors and quality of life, compared to continuous training.


Condition or disease Intervention/treatment Phase
Coronary Artery Disease Myocardial Infarction Other: Interval exercise training Other: Continuous exercise training Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 84 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Comparison Between Moderate-high Interval Exercise and Moderate Continuous Exercise in an Advanced Cardiac Rehabilitation Program - Nine Months Follow up
Study Start Date : May 2011
Actual Primary Completion Date : May 2015
Actual Study Completion Date : May 2015

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Interval exercise
Exercise bouts in low and high intensities
 Other: Interval exercise training
Exercise bouts in low and high intensities
Experimental: Continuous exercise
Exercise continuously with moderate intensity
 Other: Continuous exercise training


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Maximal functional capacity [ Time Frame: 9 months ]
    Outcome is assessed at baseline, after 3 months and at nine months


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   40 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients undergone:

    • Myocardial infarction
    • Percutaneous transluminal coronary angioplasty
    • Coronary artery bypass graft

Exclusion Criteria:

  • Patients with:

    • Severe ischemia or angina
    • Implantable cardioverter-defibrillator
    • Pacemakers transplants
    • Severe left ventricular dysfunctions
    • Uncontrolled arrhythmias
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02162290


Locations
Layout table for location information
Israel
Asaf Harofe Medical Center
Beer Yaacov, Israel
Sponsors and Collaborators
Assaf-Harofeh Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Yael Pernick Asaf Harofe Medical Center
Study Director: Zyssman, MD Asaf Harofe Medical Center
Study Director: Jonathan Moore, PhD Bangor University
Study Director: Zvi Vered, MD Asaf Harofe Medical Center
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier: NCT02162290    
Other Study ID Numbers: 2*175/10
First Posted: June 12, 2014    Key Record Dates
Last Update Posted: May 17, 2016
Last Verified: May 2016
Additional relevant MeSH terms:
Layout table for MeSH terms
Coronary Artery Disease
Myocardial Infarction
Infarction
Ischemia
Pathologic Processes
Necrosis
Coronary Disease
 Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases